| What organization runs or oversees the operation of the facility? |
| Ministry of Health |
8 |
7 |
|
7 / 8 |
| Non-governmental organization |
8 |
1 |
|
1 / 8 |
| What is the type of the facility? |
| Primary hospital |
8 |
0 |
|
0 / 8 |
| Secondary hospital |
8 |
1 |
|
1 / 8 |
| Tertiary hospital |
8 |
7 |
|
7 / 8 |
| Independent specialized facility |
8 |
0 |
|
0 / 8 |
| What specialties are available to patients with Lassa Fever in your facility? |
| Isolation unit & PEP |
8 |
8 |
|
8 / 8 |
| Intensive care beds |
8 |
7 |
|
7 / 8 |
| Mechanical ventilation |
8 |
6 |
|
6 / 8 |
| Staff trained in high dependency care |
8 |
4 |
|
4 / 8 |
| Renal dialysis |
8 |
8 |
|
8 / 8 |
| FBC |
8 |
7 |
|
7 / 8 |
| E/U/Cr |
8 |
7 |
|
7 / 8 |
| LFT |
8 |
7 |
|
7 / 8 |
| Clotting profile |
8 |
3 |
|
3 / 8 |
| Blood gas analysis |
8 |
3 |
|
3 / 8 |
| Test for cardiac and hyperinflammatory markers |
8 |
4 |
|
4 / 8 |
| PCR |
8 |
8 |
|
8 / 8 |
| Eliza |
8 |
1 |
|
1 / 8 |
| IgG |
8 |
3 |
|
3 / 8 |
| IgM |
8 |
3 |
|
3 / 8 |
| Antigen detection |
8 |
1 |
|
1 / 8 |
| Blood transfusion capability |
8 |
8 |
|
8 / 8 |
| Plasma and platelet transfusions |
8 |
3 |
|
3 / 8 |
| Pregnancy testing |
8 |
8 |
|
8 / 8 |
| EEG |
8 |
3 |
|
3 / 8 |
| ECG |
8 |
6 |
|
6 / 8 |
| High flow oxygen therapy |
8 |
6 |
|
6 / 8 |
| ICP monitoring for unconscious patients |
8 |
1 |
|
1 / 8 |
| Ultrasound |
8 |
7 |
|
7 / 8 |
| Xray |
8 |
4 |
|
4 / 8 |
| Audiometry |
8 |
4 |
|
4 / 8 |
| Haematological support |
8 |
7 |
|
7 / 8 |
| Neonatal support |
8 |
5 |
|
5 / 8 |
| Nutritional support |
8 |
7 |
|
7 / 8 |
| Psychological support |
8 |
8 |
|
8 / 8 |
| Were any of your research studies specifically focused on sub-groups? If so which sub-groups? (i.e., pediatrics, pregnant women, under 5 years and greater than 50 years? |
| Vaccine trials |
8 |
3 |
|
3 / 8 |
| Drug therapy studies |
8 |
4 |
|
4 / 8 |
| Observational studies |
8 |
7 |
|
7 / 8 |
| Patient management studies |
8 |
3 |
|
3 / 8 |
| Education/training studies (e.g., education/training for healthcare workers, education/information for patients or caregivers) |
8 |
4 |
|
4 / 8 |
| Qualitative analysis (e.g., patient experiences, healthcare worker experiences.) |
8 |
2 |
|
2 / 8 |
| Host/animal interface |
8 |
3 |
|
3 / 8 |
| Quality of care (performance indicators) |
8 |
1 |
|
1 / 8 |
| Education/training studies (e.g., education/training for healthcare workers, education/information for patients or caregivers,) |
8 |
3 |
|
3 / 8 |
| Non-clinical quantitative analysis (e.g., health system outcomes) |
8 |
2 |
|
2 / 8 |
| Were/are any of your research studies specifically focused on sub-groups? If so which sub-groups? (i.e., pediatrics, pregnant women, children between 5 – 18 years and older adults? |
| Pregnant women |
8 |
3 |
|
3 / 8 |
| Children between 5-18 years old |
8 |
3 |
|
3 / 8 |
| Individuals older than 60 years old |
8 |
0 |
|
0 / 8 |
| Immunosuppressed |
8 |
1 |
|
1 / 8 |
| Please choose the study categories that are most related to the studies conducted by the facility: |
| Drug therapy studies (e.g., drug therapy for Lassa Fever.) |
8 |
5 |
|
5 / 8 |
| Patient management studies |
8 |
5 |
|
5 / 8 |
| Quality of care (performance indicators) |
8 |
2 |
|
2 / 8 |
| Vaccine trials |
8 |
3 |
|
3 / 8 |
| Education/training studies (e.g., education/training for healthcare workers, education/information for patients or caregivers,..) |
8 |
5 |
|
5 / 8 |
| Non-clinical quantitative analysis (e.g., health system outcomes) |
8 |
2 |
|
2 / 8 |
| Qualitative analysis (e.g., patient experiences, community perception, healthcare worker experiences,..) |
8 |
5 |
|
5 / 8 |
| Reservoir – host interface |
8 |
3 |
|
3 / 8 |
| Please choose ALL clinical areas that your research consortium collects information on: |
| Post Lassa Fever complications |
8 |
5 |
|
5 / 8 |
| Sensory Hearing Loss |
8 |
3 |
|
3 / 8 |
| Viral persistence |
8 |
2 |
|
2 / 8 |
| Obstetrics |
8 |
6 |
|
6 / 8 |
| Viral lineages |
8 |
0 |
|
0 / 8 |
| Sepsis |
8 |
4 |
|
4 / 8 |
| Neurological |
8 |
6 |
|
6 / 8 |
| Hematology |
8 |
5 |
|
5 / 8 |
| Cardiovascular |
8 |
5 |
|
5 / 8 |
| Renal |
8 |
6 |
|
6 / 8 |
| Coagulopathy |
8 |
3 |
|
3 / 8 |
| Endothelial |
8 |
1 |
|
1 / 8 |
| Psychiatry |
8 |
2 |
|
2 / 8 |
| Neonatal |
8 |
1 |
|
1 / 8 |
| Vaccination |
8 |
1 |
|
1 / 8 |
| What research training has been completed in your facility? |
| Staff trained in research, ethics, compliance and safety training (CITI Program) |
8 |
8 |
|
8 / 8 |
| Staff trained in “Good Clinical Laboratory Practice” (GCLP). |
8 |
8 |
|
8 / 8 |
| Training on how to store biological samples (i.e., blood, plasma, urine, sputum). |
8 |
7 |
|
7 / 8 |